Table 4.
T1 generation
|
T2 generation
|
||||
---|---|---|---|---|---|
Lines | KR | KS | Lines | KR | KS |
L1 | 61 | 0 | L1-x | 32 | 0 |
L7 | 30 | 0 | L7-x | 79 | 0 |
L2 | 59 | 0 | L2-x | 255 | 3 |
L3r | 38 | 5 | L3r-x | 105 | 0 |
L14r | 195 | 31 | L14r-x | 331 | 0 |
L16r | 68 | 13 | L16r-x | 177 | 0 |
L4 | 134 | 45 | L4-x | 324 | 96 |
L6 | 53 | 3 | L6-x | 155 | 11 |
L17 | 124 | 34 | L17-x | 275 | 24 |
L17r | 53 | 9 | L17r-x | 317 | 29 |
L4r | 45 | 21 | L4r-x | 142 | 37 |
KR and KS: kanamycin-resistant and kanamycin-sensitive phenotypes, respectively.